Under the leadership of Chief Executive Officer Thane Wettig, Kyntra Bio’s executive team includes accomplished leaders with deep and broad experience. Supported by a lean staff, built for purpose and supported by critical external expertise, we are focused on delivering first-in-class medicines for the treatment of unmet medical needs.
Executive Team
Thane Wettig
Chief Executive Officer and Director
David DeLucia
Senior Vice President and Chief Financial Officer
John Alden
General Counsel
Mark Lonergan
Vice President of Development, Manufacturing, Supply Planning, and Supply Chain Operations
Carol Gaddum
Vice President of Product Development
Mairead Carney
Executive Director of Clinical Operations and Strategic Outsourcing
Michelle Simonetti
Executive Director, Head of People and Culture
Our Leadership
We are putting substantial expertise to work in developing novel therapeutics for cancer and rare disease.